Stay updated on LITT with Checkpoint Inhibitor for RGBM Clinical Trial

Sign up to get notified when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The recurrent glioblastoma study record is now displayed, describing a completed Phase I/II trial of laser interstitial thermotherapy combined with pembrolizumab. It also provides the study design, participant criteria, locations, and outcome measures.
    Difference
    63%
    Check dated 2026-11-09T13:50:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:49:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “artificial intelligence” to “Super Intelligence.” The study page itself remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-26T15:46:55.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T21:51:00.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:13:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Access to the study record page now renders a 403 Forbidden error, replacing the previous detailed content with an error screen. The change indicates the record is blocked or unavailable rather than updated study data.
    Difference
    21%
    Check dated 2026-09-21T22:42:12.000Z thumbnail image

Stay in the know with updates to LITT with Checkpoint Inhibitor for RGBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.